Skip to main content
Premium Trial:

Request an Annual Quote

Sera Prognostics Presents Data from Second Study on Preterm Birth Protein Biomarkers


Sera Prognostics this week presented results from a study demonstrating that its protein biomarker panel for preterm birth was able to predict incidence of that complication at 24 and 28 weeks gestation with 92 percent sensitivity and 86 percent specificity.

Based on intellectual property that Sera has licensed from the University of Utah and Brigham Young University, the panel consists of five previously identified proteins plus three proprietary peptides. In January, Sera raised $1.4 million to fund development of the test, which it hopes to launch as a CLIA diagnostic by the end of the year or early 2012 and later submit for approval with the US Food and Drug Administration (PM 01/07/2011).

The company presented the study at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco. It follows a previous study published in the November issue of the American Journal of Obstetrics and Gynecology in which the test demonstrated 86.5 percent sensitivity and 80.6 percent specificity for preterm birth at 28 weeks of pregnancy.

There are approximately 525,000 preterm births in the US each year. According to the March of Dimes, the annual public healthcare cost of caring for preterm infants is more than $26 billion. Currently there are no tests on the market for predicting whether an asymptomatic woman will go on to have an early delivery.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.